Serum hepcidin may be a novel uremic toxin, which might be related to erythropoietin resistance
出版年份 2017 全文链接
标题
Serum hepcidin may be a novel uremic toxin, which might be related to erythropoietin resistance
作者
关键词
-
出版物
Scientific Reports
Volume 7, Issue 1, Pages -
出版商
Springer Nature
发表日期
2017-06-20
DOI
10.1038/s41598-017-04664-y
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A Novel Hypoxia-Inducible Factor−Prolyl Hydroxylase Inhibitor (GSK1278863) for Anemia in CKD: A 28-Day, Phase 2A Randomized Trial
- (2016) Richard A. Brigandi et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Assessment of serum bioactive hepcidin-25, soluble transferrin receptor and their ratio in predialysis patients: Correlation with the response to intravenous ferric carboxymaltose
- (2016) Athina Drakou et al. BLOOD CELLS MOLECULES AND DISEASES
- Hepcidin Response to Iron Therapy in Patients with Non-Dialysis Dependent CKD: An Analysis of the FIND-CKD Trial
- (2016) Carlo A. Gaillard et al. PLoS One
- Iron Status and Inflammation in Early Stages of Chronic Kidney Disease
- (2015) Ewelina Łukaszyk et al. KIDNEY & BLOOD PRESSURE RESEARCH
- Correlation between hepcidin level and renal anemia
- (2014) L.-N. Yang et al. GENETICS AND MOLECULAR RESEARCH
- Serum hepcidin-25 and response to intravenous iron in patients with non-dialysis chronic kidney disease
- (2014) Sourabh Chand et al. JOURNAL OF NEPHROLOGY
- The Relation of Hepcidin to Iron Disorders, Inflammation and Hemoglobin in Chronic Kidney Disease
- (2014) Lucile Mercadel et al. PLoS One
- Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2012 Clinical Practice Guideline
- (2013) Paul E. Stevens ANNALS OF INTERNAL MEDICINE
- Hepcidin-25 Concentrations Are Markedly Increased in Patients With Chronic Kidney Disease and Are Inversely Correlated With Estimated Glomerular Filtration Rates
- (2013) Jason S. Troutt et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- Improved Mass Spectrometry Assay For Plasma Hepcidin: Detection and Characterization of a Novel Hepcidin Isoform
- (2013) Coby M. M. Laarakkers et al. PLoS One
- Dose of Erythropoiesis-Stimulating Agents and Adverse Outcomes in CKD: A Metaregression Analysis
- (2012) Ioannis Koulouridis et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Serum levels of the hepcidin-20 isoform in a large general population: The Val Borbera study
- (2012) Natascia Campostrini et al. Journal of Proteomics
- Hepcidin and iron regulation, 10 years later
- (2011) T. Ganz BLOOD
- Serum hepcidin-25 levels and anemia in non-dialysis chronic kidney disease patients: a cross-sectional study
- (2011) T. Uehata et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Immunochemical and Mass-Spectrometry-Based Serum Hepcidin Assays for Iron Metabolism Disorders
- (2010) J. J. C. Kroot et al. CLINICAL CHEMISTRY
- Hepcidin-25 is a marker of the response rather than resistance to exogenous erythropoietin in chronic kidney disease/chronic heart failure patients†
- (2010) Karien van der Putten et al. EUROPEAN JOURNAL OF HEART FAILURE
- Hepcidin--A Potential Novel Biomarker for Iron Status in Chronic Kidney Disease
- (2009) J. Zaritsky et al. Clinical Journal of the American Society of Nephrology
- Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease
- (2009) Damien R. Ashby et al. KIDNEY INTERNATIONAL
- Serum hepcidin-25 levels in patients with chronic kidney disease are independent of glomerular filtration rate
- (2009) H. P.E. Peters et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Immunoassay for human serum hepcidin
- (2008) T. Ganz et al. BLOOD
- Hepcidin: from discovery to differential diagnosis
- (2008) E. H.J.M. Kemna et al. HAEMATOLOGICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started